Novalgen Limited is a private limited company registered at Argyle House Level 3 Northside, Joel Street, Northwood Hills HA6 1NW. Its total net worth is valued to be around 0 pounds, while the fixed assets that belong to the company total up to 0 pounds. Incorporated on 2018-10-14, this 5-year-old company is run by 6 directors.
Director David V., appointed on 24 March 2023. Director Michael O., appointed on 03 January 2023. Director Scott C., appointed on 09 December 2022.
The company is officially categorised as "research and experimental development on biotechnology" (SIC: 72110). According to official records there was a name change on 2018-11-06 and their previous name was Immunocure Limited.
The last confirmation statement was sent on 2023-10-13 and the due date for the subsequent filing is 2024-10-27. Moreover, the statutory accounts were filed on 31 December 2022 and the next filing is due on 30 September 2024.
| Office Address | Argyle House Level 3 Northside |
| Office Address2 | Joel Street |
| Town | Northwood Hills |
| Post code | HA6 1NW |
| Country of origin | United Kingdom |
| Registration Number | 11621264 |
| Date of Incorporation | Sun, 14th Oct 2018 |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 31st December |
| Company age | 6 years old |
| Account next due date | Mon, 30th Sep 2024 (154 days left) |
| Account last made up date | Sat, 31st Dec 2022 |
| Next confirmation statement due date | Sun, 27th Oct 2024 (2024-10-27) |
| Last confirmation statement dated | Fri, 13th Oct 2023 |
Position: Director
Appointed: 24 March 2023
Position: Corporate Director
Appointed: 15 February 2023
Position: Director
Appointed: 03 January 2023
Position: Director
Appointed: 09 December 2022
Position: Director
Appointed: 06 January 2020
Position: Director
Appointed: 07 January 2019
Position: Director
Appointed: 07 January 2019
The register of PSCs that own or have control over the company consists of 3 names. As BizStats found, there is Convergys Capital Limited from Northwood Hills, United Kingdom. The abovementioned PSC is classified as "an uk limited company", has 25-50% voting rights and has 50,01-75% shares. The abovementioned PSC has 25-50% voting rights and has 50,01-75% shares. Another entity in the persons with significant control register is Amit N. This PSC owns 25-50% shares and has 25-50% voting rights. Then there is Ucl Business Plc, who also meets the Companies House criteria to be indexed as a PSC. This PSC has a legal form of "an uk limited company", owns 25-50% shares, has 25-50% voting rights. This PSC , owns 25-50% shares and has 25-50% voting rights.
Convergys Capital Limited
Argyle House 3rd Floor Northside, Joel Street, Northwood Hills, Middlesex, HA6 1NW, United Kingdom
| Legal authority | Companies House England And Wales |
| Legal form | Uk Limited Company |
| Country registered | England And Wales |
| Place registered | Companies House |
| Registration number | 11339543 |
| Notified on | 31 May 2019 |
| Nature of control: |
50,01-75% shares 25-50% voting rights |
Amit N.
| Notified on | 14 October 2018 |
| Ceased on | 20 March 2020 |
| Nature of control: |
25-50% voting rights 25-50% shares |
Ucl Business Plc
The Network Building 97 Tottenham Court Road, London, W1T 4TP, United Kingdom
| Legal authority | England And Wales |
| Legal form | Uk Limited Company |
| Country registered | England And Wales |
| Place registered | Companies House England And Wales |
| Registration number | 02776963 |
| Notified on | 9 January 2019 |
| Ceased on | 16 August 2019 |
| Nature of control: |
25-50% voting rights 25-50% shares |
| Immunocure | November 6, 2018 |
| Profit & Loss | |||||
|---|---|---|---|---|---|
| Accounts Information Date | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
| Balance Sheet | |||||
| Cash Bank On Hand | 2 380 428 | 4 783 897 | 3 960 282 | 2 600 995 | 2 688 464 |
| Current Assets | 3 035 491 | 5 908 660 | 5 554 711 | 4 163 157 | 3 584 797 |
| Debtors | 655 063 | 1 124 763 | 1 594 429 | 1 562 162 | 896 333 |
| Other Debtors | 655 063 | 1 097 159 | 1 564 521 | 1 562 162 | 892 176 |
| Property Plant Equipment | 66 219 | 52 529 | 927 198 | 783 830 | 584 479 |
| Other | |||||
| Accumulated Depreciation Impairment Property Plant Equipment | 2 230 | 15 920 | 146 358 | 371 467 | 609 709 |
| Additions Other Than Through Business Combinations Property Plant Equipment | 68 449 | 1 005 107 | 81 741 | 38 891 | |
| Average Number Employees During Period | 10 | 22 | 24 | 19 | 17 |
| Convertible Bonds In Issue | 234 470 | 52 153 | |||
| Creditors | 266 226 | 718 999 | 1 363 221 | 401 052 | 481 573 |
| Dividends Paid On Shares | 2 667 000 | 2 667 000 | |||
| Fixed Assets | 2 733 219 | 2 719 529 | 3 594 198 | 3 450 830 | 3 251 479 |
| Future Minimum Lease Payments Under Non-cancellable Operating Leases | 83 693 | 39 703 | 39 703 | ||
| Increase From Depreciation Charge For Year Property Plant Equipment | 2 230 | 13 690 | 130 438 | 225 109 | 238 242 |
| Intangible Assets | 2 667 000 | 2 667 000 | 2 667 000 | 2 667 000 | 2 667 000 |
| Intangible Assets Gross Cost | 2 667 000 | 2 667 000 | 2 667 000 | 2 667 000 | |
| Net Current Assets Liabilities | 2 769 265 | 5 189 661 | 4 191 490 | 3 762 105 | 3 103 224 |
| Number Equity Instruments Granted Share-based Payment Arrangement | 145 600 | 234 097 | 60 000 | 625 718 | |
| Number Equity Instruments Outstanding Share-based Payment Arrangement | 129 120 | 305 137 | 283 986 | 832 182 | |
| Other Creditors | 190 153 | 315 569 | 711 407 | 246 486 | 262 002 |
| Other Taxation Social Security Payable | 30 258 | 46 843 | 59 367 | 46 437 | 39 387 |
| Percentage Class Share Held In Subsidiary | 100 | ||||
| Property Plant Equipment Gross Cost | 68 449 | 68 449 | 1 073 556 | 1 155 297 | 1 194 188 |
| Total Assets Less Current Liabilities | 5 502 484 | 7 909 190 | 7 785 688 | 7 212 935 | 6 354 703 |
| Trade Creditors Trade Payables | 45 815 | 356 587 | 357 977 | 108 129 | 128 031 |
| Trade Debtors Trade Receivables | 27 604 | 29 908 | 4 157 | ||
| Weighted Average Exercise Price Equity Instruments Forfeited Share-based Payment Arrangement | 16 | 58 | 81 | 78 | |
| Weighted Average Exercise Price Equity Instruments Granted Share-based Payment Arrangement | 146 | 234 | 60 | 626 | |
| Weighted Average Exercise Price Equity Instruments Outstanding Share-based Payment Arrangement | 129 | 305 | 284 | 832 | |
| Type | Category | Free download | |
|---|---|---|---|
| SH01 |
Statement of Capital on 2023-07-20: 198.79 GBP filed on: 21st, July 2023 |
capital | Free Download (11 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy